Logo image of ALORD.PA

ORDISSIMO SA (ALORD.PA) Stock Fundamental Analysis

EPA:ALORD - Euronext Paris - Matif - FR0013318052 - Common Stock - Currency: EUR

0.79  +0.04 (+5.05%)

Fundamental Rating

2

Taking everything into account, ALORD scores 2 out of 10 in our fundamental rating. ALORD was compared to 28 industry peers in the Technology Hardware, Storage & Peripherals industry. The financial health of ALORD is average, but there are quite some concerns on its profitability. ALORD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALORD has reported negative net income.
In the past year ALORD had a positive cash flow from operations.
ALORD had negative earnings in 4 of the past 5 years.
In multiple years ALORD reported negative operating cash flow during the last 5 years.
ALORD.PA Yearly Net Income VS EBIT VS OCF VS FCFALORD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500K -500K -1M -1.5M

1.2 Ratios

With a Return On Assets value of -7.47%, ALORD is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
The Return On Equity of ALORD (-14.29%) is worse than 60.71% of its industry peers.
Industry RankSector Rank
ROA -7.47%
ROE -14.29%
ROIC N/A
ROA(3y)-5.49%
ROA(5y)-6.85%
ROE(3y)-8.82%
ROE(5y)-9.6%
ROIC(3y)N/A
ROIC(5y)N/A
ALORD.PA Yearly ROA, ROE, ROICALORD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

ALORD's Gross Margin of 18.49% is on the low side compared to the rest of the industry. ALORD is outperformed by 67.86% of its industry peers.
In the last couple of years the Gross Margin of ALORD has declined.
The Profit Margin and Operating Margin are not available for ALORD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.22%
GM growth 5Y-11.65%
ALORD.PA Yearly Profit, Operating, Gross MarginsALORD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

ALORD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALORD has about the same amout of shares outstanding than it did 1 year ago.
ALORD has less shares outstanding than it did 5 years ago.
ALORD has a worse debt/assets ratio than last year.
ALORD.PA Yearly Shares OutstandingALORD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALORD.PA Yearly Total Debt VS Total AssetsALORD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

Based on the Altman-Z score of 0.06, we must say that ALORD is in the distress zone and has some risk of bankruptcy.
ALORD's Altman-Z score of 0.06 is on the low side compared to the rest of the industry. ALORD is outperformed by 75.00% of its industry peers.
ALORD has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.50, ALORD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ALORD has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALORD (0.27) is better than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 0.5
Altman-Z 0.06
ROIC/WACCN/A
WACC6.49%
ALORD.PA Yearly LT Debt VS Equity VS FCFALORD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

ALORD has a Current Ratio of 1.29. This is a normal value and indicates that ALORD is financially healthy and should not expect problems in meeting its short term obligations.
ALORD has a Current ratio (1.29) which is comparable to the rest of the industry.
ALORD has a Quick Ratio of 1.29. This is a bad value and indicates that ALORD is not financially healthy enough and could expect problems in meeting its short term obligations.
ALORD has a Quick ratio (0.96) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.96
ALORD.PA Yearly Current Assets VS Current LiabilitesALORD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

ALORD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -132.68%.
The Revenue for ALORD has decreased by -59.53% in the past year. This is quite bad
The Revenue has been decreasing by -7.62% on average over the past years.
EPS 1Y (TTM)-132.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.44%
Revenue 1Y (TTM)-59.53%
Revenue growth 3Y-14.7%
Revenue growth 5Y-7.62%
Sales Q2Q%16.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALORD.PA Yearly Revenue VS EstimatesALORD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALORD.PA Yearly EPS VS EstimatesALORD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.05 -0.05 -0.1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALORD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALORD is valuated reasonably with a Price/Forward Earnings ratio of 8.52.
ALORD's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALORD is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.52
ALORD.PA Price Earnings VS Forward Price EarningsALORD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALORD is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
ALORD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALORD is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.92
EV/EBITDA 61.45
ALORD.PA Per share dataALORD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ALORD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALORD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORDISSIMO SA

EPA:ALORD (3/7/2025, 7:00:00 PM)

0.79

+0.04 (+5.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)10-29 2024-10-29
Earnings (Next)04-28 2025-04-28/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.55M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.52
P/S 0.81
P/FCF 0.92
P/OCF 0.83
P/B 0.58
P/tB 1.27
EV/EBITDA 61.45
EPS(TTM)-0.44
EYN/A
EPS(NY)0.09
Fwd EY11.73%
FCF(TTM)0.86
FCFY108.99%
OCF(TTM)0.95
OCFY119.78%
SpS0.98
BVpS1.36
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.47%
ROE -14.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.49%
FCFM 87.88%
ROA(3y)-5.49%
ROA(5y)-6.85%
ROE(3y)-8.82%
ROE(5y)-9.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.22%
GM growth 5Y-11.65%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 0.5
Debt/EBITDA 23.81
Cap/Depr 41.34%
Cap/Sales 8.7%
Interest Coverage N/A
Cash Conversion 6064.29%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.96
Altman-Z 0.06
F-Score4
WACC6.49%
ROIC/WACCN/A
Cap/Depr(3y)121.04%
Cap/Depr(5y)134.53%
Cap/Sales(3y)16.47%
Cap/Sales(5y)15.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.44%
EPS Next Y12.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-59.53%
Revenue growth 3Y-14.7%
Revenue growth 5Y-7.62%
Sales Q2Q%16.81%
Revenue Next Year0.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y133.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.44%
OCF growth 3YN/A
OCF growth 5YN/A